序号 |
标题 |
次数 |
作者 |
发布时间 |
87301 |
碘丙炔基正丁胺甲酸酯(IPBC) |
151 |
WYQ |
2024-11-21 |
87302 |
炔丙基-甲基丙烯酸酯,也被称为甲基丙烯酸丙炔基酯 |
140 |
WYQ |
2024-11-21 |
87303 |
丙炔基功能化的L-谷氨酸酯-N-羧酸内酸酐(PPLG-NCA) |
108 |
WYQ |
2024-11-21 |
87304 |
gadolinium(3+),2-[4,7,10-tris(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate |
97 |
wyh |
2024-11-21 |
87305 |
丙炔基甘氨酸(PAG) |
179 |
WYQ |
2024-11-21 |
87306 |
5-碘甲基降冰片烯 , IMNB |
128 |
kx |
2024-11-21 |
87307 |
整合素DOTA-E-[cyclo(RGDfK(Acp))]2 |
102 |
zyl |
2024-11-21 |
87308 |
DOTA-E[CYCLO(RGDFK)]2探针多肽 |
131 |
wyh |
2024-11-21 |
87309 |
DOTA-JR-11,1039726-31-2,放射显影多肽 |
122 |
zyl |
2024-11-21 |
87310 |
5-降冰片烯-2-亚甲基环氧丙基醚 , NB-MGE |
114 |
kx |
2024-11-21 |
87311 |
DO3A-Thiol ;CAS:865470-67-3 DOTA-SH |
93 |
wyh |
2024-11-21 |
87312 |
七肽DOTA-VLASSAR,CAS号:1262403-90-6 |
105 |
zyl |
2024-11-21 |
87313 |
Gd-DOTA-HCBP的组成结构 |
123 |
wyh |
2024-11-21 |
87314 |
双阳离子中心咪唑功能化降冰片烯离子液体单体 , NB-O-Im+Br--Im+Br- |
147 |
kx |
2024-11-21 |
87315 |
479081-06-6 ;DOTA-(COOt-Bu)3-NHFmoc-Lys |
116 |
wyh |
2024-11-21 |
87316 |
DOTA-TATE,CAS:177943-89-4, DOTA-3-酪氨酰基-奥曲肽 |
116 |
zyl |
2024-11-21 |
87317 |
DOTA-octreotide的组成与结构 |
106 |
wyh |
2024-11-21 |
87318 |
endo-N-3,5-双三氟甲基联苯基降冰片烯酰亚胺, endo-PTNDI |
120 |
kx |
2024-11-21 |
87319 |
DOTA-Octreotide 大环配体奥曲肽 |
132 |
zyl |
2024-11-21 |
87320 |
端丙炔基聚乙二醇(PTPEG) |
164 |
WYQ |
2024-11-21 |
87321 |
CAS:127985-74-4,DOTA-p-NCS-Bn多肽标记的双功能螯合剂 |
114 |
wyh |
2024-11-21 |
87322 |
降冰片烯-异戊二烯共聚物 ,NBE-IP |
157 |
kx |
2024-11-21 |
87323 |
cyclo(RGDFK(DOTA))的特性与功能 |
106 |
wyh |
2024-11-21 |
87324 |
DOTA-cyclo(RGDfK) |
100 |
zyl |
2024-11-21 |
87325 |
Lu-DOTA-TATE;镥-大环配体-TATE多肽 |
391 |
wyh |
2024-11-21 |
87326 |
顺-5-降冰片烯-内型-2,3-二羧酸二乙酯 , endo-NDDE |
137 |
kx |
2024-11-21 |
87327 |
DOTA-NCS,DOTA-p-NCS-Bn,cas:127985-74-4 |
110 |
zyl |
2024-11-21 |
87328 |
DOTA-PEG-CPP;大环配体DOTA-聚乙二醇-酪蛋白磷酸肽 |
115 |
wyh |
2024-11-21 |
87329 |
Gd-DOTA-COOH 钆-四氮杂环配体-羧基 |
118 |
zyl |
2024-11-21 |
87330 |
DOTA-E「cyclo(RGDfK)2 |
109 |
wyh |
2024-11-21 |
87331 |
DOTA-(Tyr3)-Octreotate;大环配体修饰多肽 |
122 |
wyh |
2024-11-21 |
87332 |
单-6-(4-甲基丙烯酸丙炔基酯-1,2,3-三氮唑)-磺酸基-β-CD(PMA-sulfated-β-CD) |
125 |
WYQ |
2024-11-21 |
87333 |
碘丙炔基正丁氨基甲酸酯(IPBC) |
176 |
WYQ |
2024-11-21 |
87334 |
Gd-DOTA-多肽 |
97 |
zyl |
2024-11-21 |
87335 |
DSPE-PEG-DOTA ;二硬脂酰基磷脂酰乙醇胺- 聚乙二醇-大环化合物 |
309 |
wyh |
2024-11-21 |
87336 |
250612-06-7 ;DOTA-RGDfK dimer |
116 |
wyh |
2024-11-21 |
87337 |
DOTA-GA(tBu)4 cas306776-79-4 大环配体化合物 |
201 |
zyl |
2024-11-21 |
87338 |
250612-06-7 DOTA多肽探针二聚体 |
93 |
wyh |
2024-11-21 |
87339 |
cas:1262403-90-6 七肽DOTA-VLASSAR |
103 |
zyl |
2024-11-21 |
87340 |
DOTA-DGln-DGln-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 |
100 |
wyh |
2024-11-21 |
87341 |
DOTA-NOC ;619300-53-7 |
110 |
wyh |
2024-11-21 |
87342 |
DOTA-奥曲肽,DOTA-Octreotide |
160 |
zyl |
2024-11-21 |
87343 |
DOTA-PEG5-amine ;DOTA-PEG5-NH2 |
98 |
wyh |
2024-11-21 |
87344 |
DOTA修饰肽,1180007-00-4,二肽Z-GGRDOTA |
99 |
zyl |
2024-11-21 |
87345 |
DOTA-PEG5-amine ;DOTA-PEG5-NH2 |
98 |
wyh |
2024-11-21 |